The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Regulatory News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Clinigen Group PLC

19 Sep 2017 15:51

Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

Neuberger Berman Group LLC - Form 8.3 - Clinigen Group PLC

PR Newswire

London, September 19

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Neuberger Berman Group LLC
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeClinigen Group PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure18/09/2017
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:0.1p Ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:3,746,9293.2500
(2) Cash-settled derivatives:0000
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:0000
TOTAL:3,746,9293.2500

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
0.1p OrdinarySell97010.417

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
none

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
none

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?No

Date of disclosure:19/09/2017
Contact name:Stacy Miller
Telephone number:646-497-4663

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
4th Apr 20224:54 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc_Amend
4th Apr 20223:29 pmRNSForm 8.3 - [Clinigen Group plc/Triley Bidco Ltd]
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
4th Apr 202212:31 pmGNWForm 8.3 - Clinigen Group PLC
4th Apr 202211:46 amGNWForm 8.3 - AXA INVESTMENT MANAGERS: Clinigen Group Plc
4th Apr 202211:09 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
4th Apr 202210:59 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
4th Apr 202210:50 amRNSScheme Becomes Effective
4th Apr 20229:50 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
4th Apr 20229:19 amRNSForm 8.5 (EPT/RI) - Clinigen Group Plc
4th Apr 20227:30 amRNSSuspension - Clinigen Group PLC
1st Apr 20223:29 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:25 pmRNSForm 8.3 - Clinigen Group
1st Apr 20223:20 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20223:00 pmRNSForm 8.3 - Clinigen Group plc
1st Apr 20221:27 pmGNWForm 8.3 - Clinigen Group PLC
1st Apr 20221:09 pmRNSForm 8.5 (EPT/RI)-Clinigen Group plc
1st Apr 202210:59 amRNSForm 8.5 (EPT/NON-RI)-CLINIGEN GROUP PLC
1st Apr 202210:52 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 202210:22 amRNSForm 8.5 (EPT/RI) - Clinigen Group PLC
1st Apr 20229:56 amRNSForm 8.3 - Clinigen Group Plc
31st Mar 20225:52 pmRNSForm 8.5 (EPT/RI)- Clinigen Group plc Amend
31st Mar 20223:30 pmGNWForm 8.3 - Clinigen Group plc
31st Mar 20223:29 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:27 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
31st Mar 202212:54 pmRNSCourt Sanction of Scheme of Arrangement
31st Mar 202212:52 pmGNWForm 8.3 - Clinigen Group PLC
31st Mar 202211:11 amRNSForm 8.3 - CLINIGEN GROUP PLC
31st Mar 202211:09 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
31st Mar 202210:48 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
31st Mar 202210:41 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
31st Mar 202210:10 amRNSForm 8.3 - Clinigen Group Plc
30th Mar 20225:30 pmRNSClinigen Group
30th Mar 20223:21 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
30th Mar 20222:42 pmRNSForm 8.3 - Clinigen Group Plc
30th Mar 20221:44 pmGNWForm 8.3 - Clinigen Group PLC
30th Mar 202211:45 amRNSForm 8.5 (EPT/NON-RI)- Clinigen Group plc
30th Mar 202211:37 amRNSForm 8.5 (EPT/RI)- Clinigen Group plc
30th Mar 202211:19 amGNWHSBC Bank Plc - Form 8.5 (EPT/RI) - Clinigen Group PLC
30th Mar 202210:49 amRNSForm 8.3 - Clinigen Group PLC
30th Mar 202210:35 amRNSForm 8.5 (EPT/NON-RI) Clinigen Group plc
30th Mar 202210:34 amRNSForm 8.3 - Clinigen Group Plc
29th Mar 20223:20 pmRNSForm 8.3 - Clinigen Group plc
29th Mar 20222:48 pmRNSForm 8.3 - Clinigen Group Plc
29th Mar 20222:43 pmRNSForm 8.3 -Clinigen Group plc
29th Mar 20221:30 pmBUSForm 8.3 - CLINIGEN GROUP PLC
29th Mar 202212:55 pmGNWForm 8.3 - Clinigen Group PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.